Anti–diabetic effect of sulfonylureas is by reducing:
**Core Concept**
Sulfonylureas are a class of anti-diabetic medications that stimulate insulin release from pancreatic beta cells. The primary mechanism of action involves the closure of potassium channels, leading to cell depolarization and subsequent insulin secretion.
**Why the Correct Answer is Right**
The correct mechanism of action of sulfonylureas involves the binding to and closure of ATP-sensitive potassium channels (K ATP channels) on the surface of pancreatic beta cells. This closure leads to cell depolarization, which opens voltage-dependent calcium channels, allowing an influx of calcium ions into the cell. The increased intracellular calcium concentration triggers the fusion of insulin-containing vesicles with the plasma membrane, resulting in the release of insulin into the bloodstream.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because sulfonylureas do not primarily work by increasing insulin sensitivity or enhancing glucose uptake in peripheral tissues.
**Option B:** This option is incorrect because sulfonylureas do not primarily work by inhibiting glucagon secretion or reducing hepatic glucose production.
**Option C:** This option is incorrect because sulfonylureas do not primarily work by activating adenosine monophosphate-activated protein kinase (AMPK) or enhancing mitochondrial biogenesis.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that sulfonylureas can cause hypoglycemia due to their ability to stimulate insulin release, especially when used in combination with other anti-diabetic medications or in patients with renal or hepatic impairment.
**Correct Answer:** B. closing potassium channels